Huntington disease as a dual diagnosis disorder: Data from the national research roster for Huntington disease patients and families

Drug and Alcohol Dependence

Volumn 86, Issue 2-3, 2007, Pages 283-286

  Ehret, Jason C ^a   Day, Patricia S ^b   Wiegand, Ryan ^c   Wojcieszek, Joanne ^a   Chambers, R Andrew ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Alcohol; Dual daignosis; Huntington disease; Nicotine; Psychiatric symptoms

Indexed keywords

ALCOHOL; NICOTINE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DATA ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MEDICAL RESEARCH; MENTAL DISEASE; PRIORITY JOURNAL; SUBSTANCE ABUSE; SYMPTOM;

AGED, 80 AND OVER; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; NATIONAL HEALTH PROGRAMS; REGISTRIES; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 33751417092     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2006.06.009     Document Type: Article

References (29)

1. Anderson K.E., Louis E.D., Stern Y., and Marder K.S. Cognitive correlates of obsessive and compulsive symptoms in Huntington's disease. Am. J. Psychiat. 158 (2001) 799-801
2. Brady K.T., and Randall C.L. Gender differences in substance use disorders. Psychiat. Clin. N. Am. 22 (1999) 241-252
3. Cantwell R., Brewin J., Glazebrook C., Dalkin T., Fox R., Medley I., and Harrison G. Prevalence of substance misuse in first-episode psychosis. Br. J. Psychiat. 164 (1999) 150-153
4. CDC. Cigarette smoking among adults, United States, 1992, and changes in the definition of current cigarette smoking. MMWR 43 (1992) 342-346
5. Chambers R.A., Krystal J.K., and Self D.W. A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol. Psychiat. 50 (2001) 71-83
6. Cummings J.L. Frontal-subcortical circuits and human behavior. Arch. Neurol. 50 (1993) 873-880
7. Currier R.D., Jackson J.F., and Meydrech E.F. Progression rate and age at onset are related in autosomal dominant neurological diseases. Neurology 32 (1982) 907-909
8. Di Maio L., Squitieri F., Napolitano G., Campanella G., Trofatter J.A., and Conneally P.M. Onset symptoms in 510 patients with Huntington's disease. J. Med. Genetics 30 (1993) 289-292
9. Dixon L. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr. Res. 35 Suppl. (1999) 93-100
10. Folstein S.E., and Folstein M.F. Psychiatric feature of Huntington's disease: recent approaches and findings. Psychiat. Develop. 2 (1983) 193-206
11. Halliday G.M., McRitchie D.A., Macdonald V., Double K.L., Trent R.J., and McCusker E. Regional specificity of brain atrophy in Huntington's disease. Exp. Neurol. 154 (1998) 663-672
12. Harper P.S. The epidemiology of Huntington's disease. Human Genetics 89 (1992) 365-376
13. Jensen P., Fenger K., Bolwig T.G., and Sorenson S.A. Crime in Huntington's disease: a study of registered offences among patients, relatives, and controls. J. Neurol. Neurosurg. Psychiat. 65 (1998) 467-471
14. Jensen P., Sorenson S.A., Fenger K., and Bolwig T.G. A study of psychiatric morbidity in patients with Huntington's disease: their relatives, and controls. Br. J. Psychiat. 163 (1993) 790-797
15. Joel D. Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease. Movement Disord. 16 (2001) 407-423
16. Kessler R.C. The epidemiology of dual diagnosis. Biol. Psychiat. 56 (2004) 730-737
17. King M. Alcohol abuse in Huntington's disease. Psychol. Med. 15 (1985) 815-819
18. Kirkwood S.C., Su J.L., Conneally P.M., and Foroud T. Progression of symptoms in the early and middle stages of Huntington disease. Arch. Neurol. 58 (2001) 273-278
19. Litvan I., Paulsen J.S., and Mega M.S. Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. Arch. Neurol. 55 (1998) 1313-1319
20. Lopez W., and Jeste D.V. Movement disorders and substance abuse. Psychiat. Serv. 48 (1997) 634-636
21. Mahant N., McCusker E.A., Byth K., Graham S., and Group H.S. Huntington's disease clinical correlates of disability and progression. Neurology 61 (2003) 1085-1092
22. Marder K., Zhao H., Myers R.H., Cudkpwicz M., Kayson E., Kieburtz K., Orme C., Penney J.B., Siemers E., Shoulson I., and Group H.S. Rate of functional decline in Huntington's disease. Neurology 54 (2000) 452-458
23. Mendez M.F. Huntington's disease: update and review of neuropsychiatric aspects. Int. J. Psychiat. Med. 24 (1994) 189-208
24. Paulsen J.S., Zhao H., Stout J.C., Brinkman R.R., Guttman M., Ross C.A., Como R., Manning C., Hayden M.R., Shoulson I., and Huntington Study Group. Clinical markers of early disease in persons near onset of Huntington's disease. Neurology 57 (2001) 658-662
25. RachBeisel J., Scott J., and Dixon L. Co-occurring severe mental illness and substance use disorders: a review of recent research. Psychiat. Serv. 50 (1999) 1427-1434
26. Siegfried N. A review of comorbidity: major mental illness and problematic substance use. Aust. NZ J. Psychiat. 32 (1998) 707-717
27. Swerdlow N.R., and Koob G.F. Dopamine, schizophrenia, mania and depression: toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behav. Brain Sci. 10 (1987) 197-245
28. Thieben M.J., Duggins A.J., Good C.D., Gomes L., Mhant N., Richards F., McCusker E., and Frackowiak R.S.J. The distribution of structural neuropathology in pre-clinical Hunitngton's disease. Brain 125 (2002) 1815-1828
29. Vonsattel J.P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., and Richardson Jr. E.P. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44 (1985) 559-577